{"product_id":"kpv-30mg","title":"KPV 30mg","description":"\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eKPV — Experimental Tripeptide for Anti-Inflammatory Research\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eKPV is a synthetic tripeptide composed of three amino acids: lysine, proline, and valine (Lys-Pro-Val).\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e It corresponds to the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH) and has attracted scientific interest for its potential anti-inflammatory properties, particularly in research involving intestinal inflammation and immune cell signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePreclinical studies have investigated KPV's effects on inflammatory pathways in laboratory cell cultures and animal models of intestinal inflammation. However, its safety and efficacy in humans have not been established through clinical trials.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eProposed Mechanism of Action\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eKPV is being investigated for its potential ability to modulate inflammatory signaling pathways and cellular immune responses.\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eInflammatory Signaling:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Laboratory studies suggest that KPV may inhibit the activation of nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways under certain experimental conditions, potentially reducing the production of specific pro-inflammatory mediators.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePeptide Transport:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Research indicates that KPV may be transported into intestinal epithelial cells and certain immune cells through the peptide transporter PepT1, potentially contributing to its observed biological activity in experimental models.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImmune Response Modulation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Preclinical findings suggest that KPV may influence inflammatory responses in selected cellular and animal models. Its precise molecular mechanisms and relevance to human physiology remain under investigation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003ePreclinical Research Findings\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eThe available scientific evidence concerning KPV is predominantly preclinical.\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCellular Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Laboratory experiments involving intestinal epithelial cells and immune cell models have examined KPV's influence on inflammatory signaling and the release of pro-inflammatory cytokines.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAnimal Studies:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Research involving mouse models of experimentally induced colitis has reported reductions in inflammatory markers and histological signs of intestinal inflammation following KPV administration.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eLimited Clinical Evidence:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e There is currently insufficient clinical evidence to establish the safety or effectiveness of KPV for treating inflammatory conditions in humans. Its pharmacokinetic characteristics, optimal administration methods, and long-term safety profile have not been adequately determined.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003ePotential Research Applications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eKPV is being explored across several areas of experimental biomedical research:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eIntestinal Inflammation Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of molecular pathways associated with inflammatory responses in the gastrointestinal tract.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eInflammatory Signaling Pathways:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Examination of NF-κB and MAPK regulation and their involvement in pro-inflammatory mediator production.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePeptide Transport Mechanisms:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Exploration of the role of PepT1 in cellular peptide uptake and the biological activity of short-chain peptides.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImmune Cell Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of interactions between small peptides, intestinal epithelial cells, and immune system responses.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese applications represent \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eexperimental research areas rather than established therapeutic indications\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCurrent evidence does not establish KPV as an effective treatment for inflammatory bowel disease, autoimmune disorders, skin conditions, or other inflammatory diseases in humans.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eDevelopment Status \u0026amp; Safety Considerations\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eKPV remains an \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eexperimental research peptide and is not an approved medication for routine clinical use\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAvailable regulatory assessments have not identified sufficient human clinical trial or exposure data to establish its safety and efficacy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eImportant safety considerations include:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUnestablished Human Safety:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e There is insufficient clinical evidence to determine the risks associated with human exposure.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eLimited Pharmacokinetic Data:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Human absorption, distribution, metabolism, and elimination have not been adequately characterized.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUnknown Immunogenicity:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e The potential for immune-related adverse reactions remains insufficiently studied.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUncertain Long-Term Effects:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Long-term toxicity and potential adverse effects in humans remain unknown.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eFindings from laboratory and animal studies cannot reliably predict clinical outcomes in humans.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Use Only\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eFOR SCIENTIFIC RESEARCH PURPOSES ONLY.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIntended exclusively for qualified professionals conducting legitimate laboratory and scientific investigations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eNot for human or veterinary use. Not intended for ingestion, injection, self-administration, or any form of clinical application.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNot intended to diagnose, treat, cure, or prevent any disease.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePEPTITAN — PRECISION. SCIENCE. RESEARCH.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":59501835157768,"sku":null,"price":160.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1078\/2942\/8488\/files\/Frasco_de_Vidro_com_Arcos_Dourados.png?v=1794657660","url":"https:\/\/peptgrind.com\/products\/kpv-30mg","provider":"peptitan","version":"1.0","type":"link"}